Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
29 /100
MEDIUM RISK
Score updated Oct 13, 2026

ENTA — Enanta Pharmaceuticals, Inc. Dilution Risk Tracker

Track ENTA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ENTA — Get alerts when the score changes →

As of October 13, 2026, Enanta Pharmaceuticals, Inc. (ENTA) has a DilutionWatch DilutionScore of 29/100, rated MEDIUM dilution risk. Enanta Pharmaceuticals, Inc. has a market capitalization of $358.24M, 29.13M shares outstanding, 133 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
10
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for ENTA.
🔔 Track ENTA — Get forecast alerts →

Market Data

Market Cap$358.24M
Shares Outstanding29.13M
Float20.06M
Cash$227.09M
Debt$186.62M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore29/100DilutionWatch score record
Shares Outstanding29.13MVerified float table or market cache
Public Float20.06MVerified float table or market cache
Market Cap$358.24MMarket data cache
Cash Runway30.6 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: FORM 4 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 15.2% shares (2026Q1 vs prior)
133 institutional holders · 33.15M shares
#1 JANUS HENDERSON GROUP PLC 7.57M shares
#2 BlackRock, Inc. 3.10M shares
#3 FARALLON CAPITAL MANAGEMENT LLC 2.87M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.55M
Days to Cover9.2
% of Float12.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2015-12-11
Form 4 INSIDER TRANSACTION 2026-08-08
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ENTA Dilution Snapshot

Enanta Pharmaceuticals, Inc. (ENTA) has a DilutionScore of 29/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ENTA's DilutionScore is currently 29/100 (Medium risk), with 2 score changes tracked over 89 days. The score deteriorated from 33/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202629/100MEDIUM53 days
Aug 14 – Aug 21, 202633/100MEDIUM7 days
Jul 16 – Aug 13, 202629/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ENTA shares outstanding have increased 0.2% from 29.02M (May 2026) to 29.08M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 18, 202629.08M20.06M▼ 0.98%
May 17, 202629.08M20.26M▲ 0.09%
May 15, 202629.08M20.24M▲ 0.13%
May 13, 202629.02M20.21M▲ 0.07%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ENTA Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ENTA files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ENTA — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ENTA
ENTA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.